Literature DB >> 1867064

Differential patterns of incorporation and remodeling among various types of bone grafts.

X Q Li1, S Stevenson, L Klein, D T Davy, J W Shaffer, V M Goldberg.   

Abstract

The early (3 months) and later (6 months) patterns of incorporation and bone formation have been evaluated histomorphometrically for different types of bone grafts; that is, vascularized and nonvascularized autografts with and without ciclosporin, and vascularized and nonvascularized dog leukocyte antigen (DLA)-mismatched allografts with and without ciclosporin. The vascularized bones were superior to the nonvascularized ones in healing and remodeling their grafted segments. In the autograft bones, ciclosporin did not alter the incorporation process 3 months after transplantation but delayed and increased the remodeling activities in the long run (6 months). Nonvascularized allografts underwent vigorous resorption, and were markedly porotic. Ciclosporin administration significantly reduced resorption and enhanced remodeling in nonvascularized allografts. The remodeling of allografts was similar to that of autografts in the presence of ciclosporin, but stopped soon after the administration of ciclosporin ceased.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1867064     DOI: 10.1159/000147062

Source DB:  PubMed          Journal:  Acta Anat (Basel)        ISSN: 0001-5180


  3 in total

1.  Mesenchymal stem cells combined with biphasic calcium phosphate ceramics promote bone regeneration.

Authors:  T L Livingston; S Gordon; M Archambault; S Kadiyala; K McIntosh; A Smith; S J Peter
Journal:  J Mater Sci Mater Med       Date:  2003-03       Impact factor: 3.896

2.  Effects of cyclosporin A on rat osteoblasts (ROS 17/2.8 cells) in vitro.

Authors:  L K McCauley; T J Rosol; C C Capen
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

Review 3.  Stem cell therapy: a novel & futuristic treatment modality for disaster injuries.

Authors:  G U Gurudutta; Neeraj Kumar Satija; Vimal Kishor Singh; Yogesh Kumar Verma; Pallavi Gupta; R P Tripathi
Journal:  Indian J Med Res       Date:  2012       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.